- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Mosaic quadrivalent influenza vaccine single nanoparticle characterization ; volume:14 ; number:1 ; day:24 ; month:2 ; year:2024 ; pages:1-12 ; date:12.2024
Scientific reports ; 14, Heft 1 (24.2.2024), 1-12, 12.2024
- Creator
-
Yang, Rong Sylvie
Traver, Maria
Barefoot, Nathan
Stephens, Tyler
Alabanza, Casper
Manzella-Lapeira, Javier
Zou, Guozhang
Wolff, Jeremy
Li, Yile
Resto, Melissa
Shadrick, William
Yang, Yanhong
Ivleva, Vera B.
Tsybovsky, Yaroslav
Carlton, Kevin
Brzostowski, Joseph
Gall, Jason G.
Lei, Q. Paula
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-54876-2
- URN
-
urn:nbn:de:101:1-2405020900018.908566894473
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yang, Rong Sylvie
- Traver, Maria
- Barefoot, Nathan
- Stephens, Tyler
- Alabanza, Casper
- Manzella-Lapeira, Javier
- Zou, Guozhang
- Wolff, Jeremy
- Li, Yile
- Resto, Melissa
- Shadrick, William
- Yang, Yanhong
- Ivleva, Vera B.
- Tsybovsky, Yaroslav
- Carlton, Kevin
- Brzostowski, Joseph
- Gall, Jason G.
- Lei, Q. Paula
- SpringerLink (Online service)
Other Objects (12)
A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses
Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach
Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine
Adjuvanted influenza vaccine dynamics
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine
Physics Models of Plasmonics: Single Nanoparticle, Complex Single Nanoparticle, Nanodimer, and Single Nanoparticle over Metallic Thin Film
A Mosaic Nanoparticle Vaccine Elicits Potent Mucosal Immune Response with Significant Cross‐Protection Activity against Multiple SARS‐CoV‐2 Sublineages
Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
Multivalent Peptide–Nanoparticle Conjugates for Influenza‐Virus Inhibition
Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine
Improved influenza vaccine responses after expression of multiple viral glycoproteins from a single mRNA
Generation and evaluation of universal influenza vaccine candidates
A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses
Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach
Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine
Adjuvanted influenza vaccine dynamics
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine
Physics Models of Plasmonics: Single Nanoparticle, Complex Single Nanoparticle, Nanodimer, and Single Nanoparticle over Metallic Thin Film
A Mosaic Nanoparticle Vaccine Elicits Potent Mucosal Immune Response with Significant Cross‐Protection Activity against Multiple SARS‐CoV‐2 Sublineages
Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
Multivalent Peptide–Nanoparticle Conjugates for Influenza‐Virus Inhibition
Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine
Improved influenza vaccine responses after expression of multiple viral glycoproteins from a single mRNA
Generation and evaluation of universal influenza vaccine candidates
A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses
Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach
Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine
Adjuvanted influenza vaccine dynamics
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine
Physics Models of Plasmonics: Single Nanoparticle, Complex Single Nanoparticle, Nanodimer, and Single Nanoparticle over Metallic Thin Film
A Mosaic Nanoparticle Vaccine Elicits Potent Mucosal Immune Response with Significant Cross‐Protection Activity against Multiple SARS‐CoV‐2 Sublineages
Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
Multivalent Peptide–Nanoparticle Conjugates for Influenza‐Virus Inhibition
Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine
Improved influenza vaccine responses after expression of multiple viral glycoproteins from a single mRNA